| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |